Autologous Killer Cell Therapy in Colon Cancer Patients
Clinical trial NCT03329664 · UNKNOWN
Trial details
- NCT number
- NCT03329664
- Sponsor
- Sabz Biomedicals
- Status
- UNKNOWN
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-02-09
- Primary completion
- 2021-09-01
- Enrollment
- 20
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.